ORYN THERAPEUTICS, Inc.
Percio Gulko serves as the Professor of Medicine and Chief of the Division of Rheumatology at the Icahn School of Medicine at Mount Sinai since April 2014. Under Percio Gulko's leadership, the division is advancing a new basic and translational research program and enhancing involvement in clinical research and drug trials focused on rheumatic diseases. Prior to this role, Percio Gulko was a Professor and Laboratory Director at the Feinstein Institute for Medical Research from October 2001 to March 2014 and held the position of Assistant Professor of Medicine and Pediatrics at Columbia University from November 1997 to September 2001. Percio Gulko completed a Rheumatology fellowship at the National Institutes of Health (NIH) from 1995 to 1997, having previously completed an Internal Medicine Residency at the Medical College of Georgia at Augusta University. The medical education began with a Doctor of Medicine degree from the Federal University of Rio Grande do Sul from 1981 to 1987.
This person is not in any teams
This person is not in any offices
ORYN THERAPEUTICS, Inc.
Oryn Therapeutics is a clinical-stage company developing a new class of drug candidates, Orynotides. These proprietary drug candidates are engineered, stable, cyclic peptides with very low immunogenicity and toxicity. They modulate pathologic inflammation and have proven effective in animal models of autoimmune and chronic inflammatory diseases such as rheumatoid arthritis and ulcerative colitis. They have proven effective in preclinical cancer models and augment natural host defense, functioning as host-directed anti-infectives against drug resistant pathogens.